What people are saying - Write a review
We haven't found any reviews in the usual places.
Symptomatic Versus Asymptomatic Diabetes
Treatment of Abnormal Lipid Metabolism in NIDDM
1 other sections not shown
Other editions - View all
ability of insulin abnormalities achieve glycemic control ambient approach beta cells blood glucose calories carbohydrate centration chlorpropamide Clin clinical cose defects develop diabetes mellitus DIABINESE diagnosis diet dietary dose drugs exercise training programs fasting hyperglycemia fasting plasma glucose G. M. Reaven glipizide glipizide treatment glucose tolerance test GLUCOTROL glycemia glycemic control glycosylated hemoglobin goal HDL-cholesterol hyperglycemia hyperinsulinemia hypertriglyceridemia IDDM IGT or NIDDM improve glycemic control initiated insulin action insulin resistance insulin secretion insulin treatment insulin-stimulated glucose uptake journal and authors lipid metabolism lipoprotein lower plasma glucose mg/dl non-insulin-dependent diabetes normal glucose tolerance obese occur patients with IGT patients with NIDDM physical activity plasma FFA concentration plasma glucose concentration plasma glucose level plasma insulin concentrations plasma insulin levels plasma insulin response plasma TG concentration risk shown in Figure SSPI sucrose sulfonylurea compounds sulfonylurea treatment syndrome therapeutic therapy tients tion tolbutamide treatment of NIDDM VLDL-TG weight loss